AI and Machine Learning in Formulation Development

Artificial Intelligence (AI) and Machine Learning (ML) are transforming the pharmaceutical industry by introducing data-driven, predictive, and highly personalized approaches to drug formulation and delivery. These technologies are revolutionizing traditional practices by enhancing formulation accuracy, accelerating development timelines, and reducing costs. From solid oral dosage forms and 3D-printed medications to nanomedicine, injectable biologics, and intelligent medical devices, AI applications are enabling more precise, effective, and tailored treatments. This review explores the capabilities of AI and ML in pharmaceutical formulation, highlighting their use in optimizing drug release, predicting stability, and streamlining manufacturing processes. It discusses the integration of neural networks, natural language processing, and computer vision, while also acknowledging current limitations such as data quality, model transparency, and regulatory challenges. Furthermore, it presents case studies from leading pharmaceutical innovators and outlines the future direction of AI/ML technologies in advancing personalized medicine and improving patient outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-13
DOI
https://doi.org/10.5281/zenodo.17339741
Primary Topic
DNA and Biological Computing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI and Machine Learning in Formulation Development

Zenodo (CERN European Organization for Nuclear Research)
DNA and Biological Computing
article

AI and Machine Learning in Formulation Development

article en

Abstract

Artificial Intelligence (AI) and Machine Learning (ML) are transforming the pharmaceutical industry by introducing data-driven, predictive, and highly personalized approaches to drug formulation and delivery. These technologies are revolutionizing traditional practices by enhancing formulation accuracy, accelerating development timelines, and reducing costs. From solid oral dosage forms and 3D-printed medications to nanomedicine, injectable biologics, and intelligent medical devices, AI applications are enabling more precise, effective, and tailored treatments. This review explores the capabilities of AI and ML in pharmaceutical formulation, highlighting their use in optimizing drug release, predicting stability, and streamlining manufacturing processes. It discusses the integration of neural networks, natural language processing, and computer vision, while also acknowledging current limitations such as data quality, model transparency, and regulatory challenges. Furthermore, it presents case studies from leading pharmaceutical innovators and outlines the future direction of AI/ML technologies in advancing personalized medicine and improving patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 44%
DNA and Biological Computing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

AI and Machine Learning in Formulation Development · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS